Literature DB >> 19550143

1-O-Hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol (Gln) induces cell death with more autophagosomes which is autophagy-independent.

Luca Jahreiss1, Maurizio Renna, Robert Bittman, Gilbert Arthur, David C Rubinsztein.   

Abstract

Autophagic cell death has recently received a great deal of attention. However, a dependence of this type of cell death on the actual process of autophagy has only rarely been proven. Indeed, it is important to differentiate between cell death with an accumulation of autophagosomes and cell death actually caused by excessive or inhibited autophagy. The aim of this study was to elucidate the mechanism of action involved in the cytotoxicity of 1-O-hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol (Gln) and specifically the involvement of autophagy in the effects observed. Our results show that Gln induces cell death associated with large increases in autophagolysosome number and size. However the cell death is independent of autophagy and caspase activation. Instead, Gln leads to lysosomal membrane permeabilization with a resulting leakage of hydrolases into the cytosol, which are then directly involved in cell death. The increased number of autophagolysosomes, however, is just a side effect of the neutralization of the lysosomal pH by Gln.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550143     DOI: 10.4161/auto.9120

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  8 in total

1.  Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection.

Authors:  Maurizio Renna; Catherine Schaffner; Karen Brown; Shaobin Shang; Marcela Henao Tamayo; Krisztina Hegyi; Neil J Grimsey; David Cusens; Sarah Coulter; Jason Cooper; Anne R Bowden; Sandra M Newton; Beate Kampmann; Jennifer Helm; Andrew Jones; Charles S Haworth; Randall J Basaraba; Mary Ann DeGroote; Diane J Ordway; David C Rubinsztein; R Andres Floto
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

2.  Autophagic substrate clearance requires activity of the syntaxin-5 SNARE complex.

Authors:  Maurizio Renna; Catherine Schaffner; Ashley R Winslow; Fiona M Menzies; Andrew A Peden; R Andres Floto; David C Rubinsztein
Journal:  J Cell Sci       Date:  2011-02-01       Impact factor: 5.285

3.  Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells.

Authors:  Amani I Moraya; Jennifer L Ali; Pranati Samadder; Lisa Liang; Ludivine Coudière Morrison; Tamra E Werbowetski-Ogilvie; Makanjuola Ogunsina; Frank Schweizer; Gilbert Arthur; Mark W Nachtigal
Journal:  J Exp Clin Cancer Res       Date:  2017-05-12

4.  Unconventional secretion of α-Crystallin B requires the Autophagic pathway and is controlled by phosphorylation of its serine 59 residue.

Authors:  M D'Agostino; G Scerra; M Cannata Serio; M G Caporaso; S Bonatti; M Renna
Journal:  Sci Rep       Date:  2019-11-15       Impact factor: 4.379

Review 5.  The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer.

Authors:  Mark W Nachtigal; Alon D Altman; Rajat Arora; Frank Schweizer; Gilbert Arthur
Journal:  Cancers (Basel)       Date:  2022-07-07       Impact factor: 6.575

6.  Stat3 controls cell death during mammary gland involution by regulating uptake of milk fat globules and lysosomal membrane permeabilization.

Authors:  Timothy J Sargeant; Bethan Lloyd-Lewis; Henrike K Resemann; Antonio Ramos-Montoya; Jeremy Skepper; Christine J Watson
Journal:  Nat Cell Biol       Date:  2014-10-05       Impact factor: 28.824

7.  Dual PI-3 kinase/mTOR inhibition impairs autophagy flux and induces cell death independent of apoptosis and necroptosis.

Authors:  Robert W Button; Joseph H Vincent; Conor J Strang; Shouqing Luo
Journal:  Oncotarget       Date:  2016-02-02

8.  PICALM modulates autophagy activity and tau accumulation.

Authors:  Kevin Moreau; Angeleen Fleming; Sara Imarisio; Ana Lopez Ramirez; Jacob L Mercer; Maria Jimenez-Sanchez; Carla F Bento; Claudia Puri; Eszter Zavodszky; Farah Siddiqi; Catherine P Lavau; Maureen Betton; Cahir J O'Kane; Daniel S Wechsler; David C Rubinsztein
Journal:  Nat Commun       Date:  2014-09-22       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.